Back to Geode Capital Management, LLC Geode Capital Management, LLC

RNAC

Showing 9 of 10 quarters

Position history for Geode Capital Management, LLCGeode Capital Management, LLC's holdings in Cartesian Therapeutics, Inc.

Yes. Geode Capital Management holds 342,829 shares of RNAC (Cartesian Therapeutics), worth $2.5M, as of its Q3 2026 13F filing. It reduced the position by 13,696 shares (-3.8%) from Q2 2026. Geode Capital Management has held RNAC in every 13F on record since Q2 2024, 10 quarterly filings.

Current Value

$2.5M

Current Shares

342,829

Total Value Change

+$284,467

Total Shares Change

+207,129

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
342,829
-3.8%
$2.5M0.0%$7.21
0
2026-Q2
Increased
356,525
+35.2%
$3.7M0.0%$10.42
34
2026-Q1
Increased
263,694
+3.2%
$1.6M0.0%$6.15
26
2025-Q4
Increased
255,539
+5.7%
$1.8M0.0%$7.21
27
2025-Q3
Increased
241,829
+10.5%
$2.5M0.0%$10.22
29
2025-Q2
Decreased
218,927
-2.9%
$2.3M0.0%$10.39
0
2025-Q1
Increased
225,500
+1.9%
$3M0.0%$13.18
27
2024-Q4
Increased
221,257
+63.0%
$4M0.0%$17.91
39
2024-Q3
Increased
135,700
+2.1%
$2.2M0.0%$16.12
26

Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC

Optional analytics helps us improve. How it’s used